145 related articles for article (PubMed ID: 19879533)
1. Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation.
Aggarwal A; Wang Y; Rumsfeld JS; Curtis JP; Heidenreich PA;
Heart Rhythm; 2009 Nov; 6(11):1565-71. PubMed ID: 19879533
[TBL] [Abstract][Full Text] [Related]
2. Outcome of Subcutaneous Implantable Cardioverter Defibrillator Implantation in Patients with End-Stage Renal Disease on Dialysis.
El-Chami MF; Levy M; Kelli HM; Casey M; Hoskins MH; Goyal A; Langberg JJ; Patel A; Delurgio D; Lloyd MS; Leon AR; Merchant FM
J Cardiovasc Electrophysiol; 2015 Aug; 26(8):900-904. PubMed ID: 25952566
[TBL] [Abstract][Full Text] [Related]
3. Implantable cardioverter-defibrillators with end stage renal disease: Nationwide inpatient sample database results.
Ayoub K; Fry E; Marji M; Masri A; Hesselson A; Ellison K
Pacing Clin Electrophysiol; 2022 Jan; 45(1):124-131. PubMed ID: 34806769
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of subcutaneous implantable cardioverter-defibrillator implantation in patients on hemodialysis.
Koman E; Gupta A; Subzposh F; Saltzman H; Kutalek SP
J Interv Card Electrophysiol; 2016 Mar; 45(2):219-23. PubMed ID: 26768264
[TBL] [Abstract][Full Text] [Related]
5. Cardiac perforation from implantable cardioverter-defibrillator lead placement: insights from the national cardiovascular data registry.
Hsu JC; Varosy PD; Bao H; Dewland TA; Curtis JP; Marcus GM
Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):582-90. PubMed ID: 24002030
[TBL] [Abstract][Full Text] [Related]
6. End-stage renal disease predicts complications in pacemaker and ICD implants.
Tompkins C; McLean R; Cheng A; Brinker JA; Marine JE; Nazarian S; Spragg DD; Sinha S; Halperin H; Tomaselli GF; Berger RD; Calkins H; Henrikson CA
J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1099-104. PubMed ID: 21489029
[TBL] [Abstract][Full Text] [Related]
7. Procedural outcomes and long-term survival following trans-venous defibrillator lead extraction in patients with end-stage renal disease.
Shah AD; Peddareddy LP; Addish MA; Kelly K; Patel AU; Casey M; Goyal A; Leon AR; El-Chami MF; Merchant FM
Europace; 2017 Dec; 19(12):1994-2000. PubMed ID: 28065887
[TBL] [Abstract][Full Text] [Related]
8. Procedure timing as a predictor of inhospital adverse outcomes from implantable cardioverter-defibrillator implantation: insights from the National Cardiovascular Data Registry.
Hsu JC; Varosy PD; Parzynski CS; Chaudhry SI; Dewland TA; Curtis JP; Marcus GM
Am Heart J; 2015 Jan; 169(1):45-52.e3. PubMed ID: 25497247
[TBL] [Abstract][Full Text] [Related]
9. Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients.
Robin J; Weinberg K; Tiongson J; Carnethon M; Reddy M; Ciaccio C; Quadrini M; Hsu J; Fan J; Choi P; Kadish A; Goldberger J; Passman R
Heart Rhythm; 2006 Oct; 3(10):1196-201. PubMed ID: 17018351
[TBL] [Abstract][Full Text] [Related]
10. Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry.
Dewland TA; Pellegrini CN; Wang Y; Marcus GM; Keung E; Varosy PD
J Am Coll Cardiol; 2011 Aug; 58(10):1007-13. PubMed ID: 21867834
[TBL] [Abstract][Full Text] [Related]
11. Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database.
MacFadden DR; Crystal E; Krahn AD; Mangat I; Healey JS; Dorian P; Birnie D; Simpson CS; Khaykin Y; Pinter A; Nanthakumar K; Calzavara AJ; Austin PC; Tu JV; Lee DS
Ann Intern Med; 2012 Feb; 156(3):195-203. PubMed ID: 22312139
[TBL] [Abstract][Full Text] [Related]
12. Trends in Use and In-Hospital Outcomes of Subcutaneous Implantable Cardioverter Defibrillators in Patients Undergoing Long-Term Dialysis.
Pun PH; Parzynski CS; Friedman DJ; Sanders G; Curtis JP; Al-Khatib SM
Clin J Am Soc Nephrol; 2020 Nov; 15(11):1622-1630. PubMed ID: 32967922
[TBL] [Abstract][Full Text] [Related]
13. Low body mass index but not obesity is associated with in-hospital adverse events and mortality among implantable cardioverter-defibrillator recipients: insights from the National Cardiovascular Data Registry.
Hsu JC; Varosy PD; Bao H; Wang Y; Curtis JP; Marcus GM
J Am Heart Assoc; 2012 Dec; 1(6):e003863. PubMed ID: 23316325
[TBL] [Abstract][Full Text] [Related]
14. Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
Borne RT; Peterson PN; Greenlee R; Heidenreich PA; Wang Y; Curtis JP; Tzou WS; Varosy PD; Kremers MS; Masoudi FA
Circulation; 2014 Sep; 130(10):845-53. PubMed ID: 25095884
[TBL] [Abstract][Full Text] [Related]
15. Predictors of an inadequate defibrillation safety margin at ICD implantation: insights from the National Cardiovascular Data Registry.
Hsu JC; Marcus GM; Al-Khatib SM; Wang Y; Curtis JP; Sood N; Parker MW; Kluger J; Lampert R; Russo AM
J Am Coll Cardiol; 2014 Jul; 64(3):256-64. PubMed ID: 25034061
[TBL] [Abstract][Full Text] [Related]
16. Mortality, sudden death and indication for cardioverter defibrillator implantation in a dialysis population.
Genovesi S; Porcu L; Luise MC; Riva H; Nava E; Stella A; Pozzi C; Ondei P; Minoretti C; Gallieni M; Pontoriero G; Conte F; Torri V; Vincenti A
Int J Cardiol; 2015; 186():170-7. PubMed ID: 25819895
[TBL] [Abstract][Full Text] [Related]
17. In-hospital complications associated with reoperations of implantable cardioverter defibrillators.
Steckman DA; Varosy PD; Parzynski CS; Masoudi FA; Curtis JP; Sauer WH; Nguyen DT
Am J Cardiol; 2014 Aug; 114(3):419-26. PubMed ID: 24927972
[TBL] [Abstract][Full Text] [Related]
18. Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database.
Krahn AD; Lee DS; Birnie D; Healey JS; Crystal E; Dorian P; Simpson CS; Khaykin Y; Cameron D; Janmohamed A; Yee R; Austin PC; Chen Z; Hardy J; Tu JV;
Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):136-42. PubMed ID: 21325209
[TBL] [Abstract][Full Text] [Related]
19. Defibrillator implantations for primary prevention in the United States: Inappropriate care or inadequate documentation: Insights from the National Cardiovascular Data ICD Registry.
Kaiser DW; Tsai V; Heidenreich PA; Goldstein MK; Wang Y; Curtis J; Turakhia MP;
Heart Rhythm; 2015 Oct; 12(10):2086-93. PubMed ID: 25982720
[TBL] [Abstract][Full Text] [Related]
20. Implantable Cardioverter-Defibrillators in Patients with ESRD: Complications, Management, and Literature Review.
Mehdi B; Kaveh H; Ali VF
Curr Cardiol Rev; 2019; 15(3):161-166. PubMed ID: 30657044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
